Article
eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma.
BMC cancer - 12 Jul 2024
Bian Yingzhen, Liu Haizhou, Huang Jinglei, Feng Zhaorong, Lin Yanyan, Li Jilin, Zhang Litu
Abstract excerpt
PURPOSE: Extracellular heat shock protein 90 AA1(eHSP90α) is intricately linked to tumor progression and prognosis. This study aimed to investigate the difference in the value of eHSP90α in post-treatment response assessment and prognosis prediction between exon 19 deletion(19DEL) and exon 21 Leu858Arg(L858R) mutation types in lung adenocarcinoma(LUAD). METHODS: We analyzed the relationship between the expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
